Las Vegas is set to host a significant gathering of Alzheimer’s and Parkinson’s disease research leaders this week, as the Global Alzheimer’s Platform Foundation (GAP) convenes its annual conference from February 25th through February 27th at the Red Rock Casino Resort & Spa. The event will bring together nearly 250 representatives from over 100 clinical research sites, pharmaceutical companies, and technology partners.
Collaboration to Accelerate Research
The conference focuses on improving clinical trials and accelerating the development of treatments for Alzheimer’s and other neurodegenerative diseases. Attendees include representatives from Abbvie, Anavex, Biogen, Eisai, Eli Lilly and Co, Roche, and UNLV, among others [Global Alzheimer’s Platform Foundation].
UNLV Partnership for Next-Generation Research
https://googleads.g.doubleclick.net/pagead/ads?gdpr=0&us_privacy=1—&gpp_sid=-1&client=ca-pub-0928966750491324&output=html&h=280&adk=580248363&adf=71470487&w=609&fwrn=4&fwrnh=1
A key highlight of the conference will be the announcement of a latest partnership between GAP and the University of Nevada, Las Vegas (UNLV). This collaboration aims to accelerate the development of new biomarker and diagnostic tests for Alzheimer’s and other central nervous system (CNS) diseases, as well as expand access to related clinical trials [UNLV News]. The partnership emphasizes the importance of including participants from diverse communities in clinical trials.
Expanding Clinical Trial Access in Southern Nevada
The collaboration between UNLV and GAP seeks to bolster research on CNS diseases and increase the workforce supporting it. With nearly 7 million Americans currently living with Alzheimer’s, the need for effective clinical trials is paramount [UNLV News]. UNLV President Keith E. Whitfield stated the collaboration will give more Southern Nevadans access to clinical trials and offer students real-world research experiences.
Industry Support and Future Directions
GAP President John Dwyer will address the research progress made over the past decade and outline future directions for the organization. The conference represents an important step in the ongoing effort to combat Alzheimer’s and related diseases [Global Alzheimer’s Platform Foundation]. Clinical Neurology Specialists in Las Vegas has also been welcomed into the #BioHermes002 study, further demonstrating the growing research presence in the region [Global Alzheimer’s Platform Foundation – Facebook].